Document is current
Any future updates will be listed below
-
Authors
Hertel, Austin T.
McMillen, Cynthia M.
Hoehl, Ryan M.
Barbeau, Dominique J.
McElroy, Anita K.
Hartman, Amy L.
-
Funding
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (T32 AI060525)
National Institute of Allergy and Infectious Diseases (T32 AI060525)
National Institute of Allergy and Infectious Diseases (R01 AI150792)
National Institute of Allergy and Infectious Diseases (R01 AI150792)
National Institute of Allergy and Infectious Diseases (R01 AI150792)
National Institute of Allergy and Infectious Diseases (R01 AI150792)
- License Information
-
More Information
Article History
Received: 28 April 2025
Accepted: 14 July 2025
First Online: 25 July 2025
Competing interests
: A.K.M. receives support from UC Davis as part of their CEPI-funded efforts towards advancing DDVax as a human vaccine candidate. All other authors declare no financial or non-financial competing interests.
